- 
                        <![CDATA[Roflumilast Cream 0.05% Now Commercially Available for Pediatric Atopic Dermatitis]]>
                        30 Oct 2025 18:33 GMT
                         … of mild to moderate atopic dermatitis (AD) in pediatric  … the underlying inflammation of atopic dermatitis. ZORYVE provides a foundation …  firsthand how challenging atopic dermatitis can be for young  …  the treatment of atopic dermatitis in children ages 2 … 
- 
                        Frequent Flares Signal Worse Disease Course in Atopic Dermatitis, Machine Learning Study Finds
                        30 Oct 2025 15:54 GMT
                        
                           …  the chronic skin condition.
                          Atopic dermatitis is known for its unpredictable …  treatment target in managing atopic dermatitis more effectively. Ultimately, these findings …  Severity in Patients With Atopic Dermatitis Using Machine Learning. JAMA Dermatol …
                         
- 
                        Arcutis Launches ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Children Ages 2 to 5
                        30 Oct 2025 12:00 GMT
                         …  significant clearance of atopic dermatitis signs and symptoms and  … inflammatory dermatoses combined — atopic dermatitis, seborrheic dermatitis, and plaque psoriasis. ZORYVE …  for atopic dermatitis, plaque psoriasis, and seborrheic dermatitis to win  … 
- 
                        Prurigo Nodularis Greatly Increases Risk of Atopic Diseases, Especially Atopic Dermatitis, suggests study
                        28 Oct 2025 11:22 GMT
                        
                           …  other atopic diseases, especially atopic dermatitis (AD). The study identifies that …  disorders.
                          • The risk for atopic dermatitis (AD) was significantly increased, with …  significant association being at atopic dermatitis. The data supports integrated care …
                         
- 
                        Opzelura shows strong results in phase 3b trial for moderate atopic dermatitis
                        28 Oct 2025 10:44 GMT
                         … ) in adults with moderate atopic dermatitis (AD), revealing significant improvements in … 
- 
                        Eczema’s hidden burden: How inflammation, diet and mental health intersect in atopic dermatitis
                        28 Oct 2025 05:43 GMT
                        
                           …  mental health intersect in atopic dermatitis
                          Eczema, also known as atopic …  dermatitis, is one of the most  …  dietary role: Eczema, particularly atopic dermatitis, is a chronic inflammatory skin …
                         
- 
                        Incyte reports Phase IIIb data of ruxolitinib cream for atopic dermatitis
                        27 Oct 2025 17:52 GMT
                         … ) for adults with moderate atopic dermatitis (AD) who had contraindications, inadequate … 
- 
                        <![CDATA[AHEAD Recommendations on Atopic Dermatitis Treatment Targets]]>
                        27 Oct 2025 13:10 GMT
                         …  for treatment targets in atopic dermatitis, offering clinicians clear milestones for … 
- 
                        Eli Lilly’s Ebglyss shows sustained skin clearance in atopic dermatitis trial
                        27 Oct 2025 11:06 GMT
                         …  for moderate-to-severe atopic dermatitis (AD) in the Phase III … 
- 
                        A trade union to defend the rights of Tunisia's women farm labourers
                        31 Oct 2025 05:07 GMT
                        
                           …  cancer, chronic bronchitis, infertility or dermatitis,” she adds.
                          Despite these difficulties …